127 related articles for article (PubMed ID: 12642825)
1. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study.
Moretti ME; Caprara D; Coutinho CJ; Bar-Oz B; Berkovitch M; Addis A; Jovanovski E; Schüler-Faccini L; Koren G
J Allergy Clin Immunol; 2003 Mar; 111(3):479-83. PubMed ID: 12642825
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an association between loratadine and hypospadias--United States, 1997-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Mar; 53(10):219-21. PubMed ID: 15029117
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Aharonovich A; Moerman L; Arnon J; Wajnberg R; Ornoy A
J Allergy Clin Immunol; 2003 Jun; 111(6):1239-43. PubMed ID: 12789223
[TBL] [Abstract][Full Text] [Related]
4. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis.
Schwarz EB; Moretti ME; Nayak S; Koren G
Drug Saf; 2008; 31(9):775-88. PubMed ID: 18707192
[TBL] [Abstract][Full Text] [Related]
5. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review.
Gilbert C; Mazzotta P; Loebstein R; Koren G
Drug Saf; 2005; 28(8):707-19. PubMed ID: 16048356
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
Hernández Colín D; González Díaz SN; Rodríguez Medina R; Aguilar Angeles D; González Gámez J; Becerril Angeles M; Orea Solano M; Domínguez Henkel R; Segovia Ayala C
Rev Alerg Mex; 2004; 51(1):23-8. PubMed ID: 15119752
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Prenner B; Anolik R; Danzig M; Yao R
Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
[TBL] [Abstract][Full Text] [Related]
8. Loratadine during pregnancy and hypospadias.
Pedersen L; Nørgaard M; Rothman KJ; Sørensen HT
Epidemiology; 2008 Mar; 19(2):359-60. PubMed ID: 18277174
[No Abstract] [Full Text] [Related]
9. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
Anolik R;
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to loratadine in children with hypospadias: a nested case-control study within the Danish National Birth Cohort.
Pedersen L; Nørgaard M; Skriver MV; Olsen J; Sørensen HT
Am J Ther; 2006; 13(4):320-4. PubMed ID: 16858167
[TBL] [Abstract][Full Text] [Related]
11. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.
Prenner BM; Lu S; Danzig MR
Allergy Asthma Proc; 2010; 31(6):493-8. PubMed ID: 21708061
[TBL] [Abstract][Full Text] [Related]
12. Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.
Thomseth V; Cejvanovic V; Jimenez-Solem E; Poulsen HE; Utheim TP; Andersen JT
Acta Ophthalmol; 2019 Aug; 97(5):505-509. PubMed ID: 30479070
[TBL] [Abstract][Full Text] [Related]
13. Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures.
Dawson AL; Razzaghi H; Arth A; Canfield MA; Parker SE; Reefhuis J;
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):703-12. PubMed ID: 25884728
[TBL] [Abstract][Full Text] [Related]
14. Loratadine provides early symptom control in seasonal allergic rhinitis.
Kaiser HB; Gopalan G; Chung W
Allergy Asthma Proc; 2008; 29(6):654-8. PubMed ID: 18831859
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, parallel-group study to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine combination with that of a twice-daily loratadine-pseudoephedrine combination in the treatment of allergic rhinitis.
Chen YA; Chang KP; Lin YS; Hao SP
Eur Arch Otorhinolaryngol; 2007 Sep; 264(9):1019-25. PubMed ID: 17464511
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of serious injury following an initial prescription for diphenhydramine.
Finkle WD; Adams JL; Greenland S; Melmon KL
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):244-50. PubMed ID: 12269643
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study.
Loebstein R; Lalkin A; Addis A; Costa A; Lalkin I; Bonati M; Koren G
J Allergy Clin Immunol; 1999 Nov; 104(5):953-6. PubMed ID: 10550738
[TBL] [Abstract][Full Text] [Related]
18. The safety of metoclopramide use in the first trimester of pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
[TBL] [Abstract][Full Text] [Related]
19. [Seasonal allergic rhinitis. Nasal obstruction can also beh improved].
MMW Fortschr Med; 2001 May; 143(18):50. PubMed ID: 11387710
[No Abstract] [Full Text] [Related]
20. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
